Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients

被引:34
作者
Jin, Jae-Kwang
Kim, Nam-Ho
Lee, Yun-Jung
Kim, Yong-Sun
Choi, Eun-Kyoung
Kozlowski, Piotr B.
Park, Mi Hee
Kim, Heui-Soo
Min, Do Sik
机构
[1] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea
[2] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, South Korea
[3] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA
[4] Pusan Natl Univ, Dept Biol, Coll Nat Sci, Pusan 609735, South Korea
关键词
Alzheimer's disease; mitochondrial dysfunction; phospholipase D; phosphatidylcholine; phosphatidic acid;
D O I
10.1016/j.neulet.2006.08.062
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondrial dysfunction may play an important role in sporadic Alzheimer's disease (AD) progression. Recently, we have reported that amyloid precursor protein (APP) stimulates phospholipase D (PLD) activity and beta-amyloid (A beta) region of APP is involved in the interaction with PLD1. To elucidate the involvement of PLD in the pathophysiology of AD, we examined the expression of PLD1 and alteration of membrane phospholipid in mitochondrial membranes of control and AD brains using Western blot and phospholipid analysis by thin layer chromatography (TLC). We have found that protein expression of PLD1 was significantly increased in mitochondrial fraction of brains of AD patients compared with that in control brains. Furthermore, the concentration of mitochondrial phospholipids such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE) was increased and the content of phosphatidic acid (PA), a product of PLD activity, was up-regulated in the mitochondrial membrane fractions of AD brain compared with that of control brain. These results suggest that up-regulation of PLD I in the mitochondrial fraction of AD brain might affect the composition of membrane phospholipids and provide a clue to the mechanism underlying the mitochondrial dysfunction associated with AD. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 50 条
  • [31] CHI3L2 Expression Levels Are Correlated with AIF1, PECAM1, and CALB1 in the Brains of Alzheimer’s Disease Patients
    Cristina Sanfilippo
    Paola Castrogiovanni
    Rosa Imbesi
    Michelino Di Rosa
    Journal of Molecular Neuroscience, 2020, 70 : 1598 - 1610
  • [32] CHI3L2 Expression Levels Are Correlated with AIF1, PECAM1, and CALB1 in the Brains of Alzheimer's Disease Patients
    Sanfilippo, Cristina
    Castrogiovanni, Paola
    Imbesi, Rosa
    Di Rosa, Michelino
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2020, 70 (10) : 1598 - 1610
  • [33] Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease
    Gauba, Esha
    Chen, Hao
    Guo, Lan
    Du, Heng
    NEUROBIOLOGY OF DISEASE, 2019, 121 : 138 - 147
  • [34] Immunohistochemical Determination of HIF, TSP-1, ADAMTS1, and ADAMTS8 Expressions in the Brains of Alzheimer's Disease Patients: A Preliminary Autopsy Study
    Inanir, Nursel Turkmen
    Eren, Filiz
    Fedakar, Recep
    Eren, Bulent
    Demircan, Kadir
    Gurses, Murat Serdar
    Ural, Mustafa
    Akyol, Sumeyya
    Aynekin, Busra
    ERCIYES MEDICAL JOURNAL, 2016, 38 (01) : 1 - 5
  • [35] Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks
    Eysert, Fanny
    Kinoshita, Paula-Fernanda
    Lagarde, Julien
    Lacas-Gervais, Sandra
    Xicota, Laura
    Dorothee, Guillaume
    Bottlaender, Michel
    Checler, Frederic
    Potier, Marie-Claude
    Sarazin, Marie
    Chami, Mounia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [36] 20S proteasome and glyoxalase 1 activities decrease in erythrocytes derived from Alzheimer's disease patients
    Lv, Hui
    Wei, Gui-Yuan
    Guo, Can-Shou
    Deng, Yu-Feng
    Jiang, Yong-Ming
    Gao, Ce
    Jian, Chong-Dong
    NEURAL REGENERATION RESEARCH, 2020, 15 (01) : 178 - 183
  • [37] 20S proteasome and glyoxalase 1 activities decrease in erythrocytes derived from Alzheimer's disease patients
    Hui Lv
    Gui-Yuan Wei
    Can-Shou Guo
    Yu-Feng Deng
    Yong-Ming Jiang
    Ce Gao
    Chong-Dong Jian
    Neural Regeneration Research, 2020, (01) : 178 - 183
  • [38] Amyloid-β Peptides in Plasma and Cognitive Decline After 1 Year Follow-Up in Alzheimer's Disease Patients
    Laske, Christoph
    Sopova, Kateryna
    Gkotsis, Christos
    Eschweiler, Gerhard W.
    Straten, Guido
    Gawaz, Meinrad
    Leyhe, Thomas
    Stellos, Konstantinos
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1263 - 1269
  • [39] Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats
    Mansour, Heba M.
    Fawzy, Hala M.
    El-Khatib, Aiman S.
    Khattab, Mahmoud M.
    NEUROCHEMISTRY INTERNATIONAL, 2021, 150
  • [40] APOE ε4 allele, along with G206D-PSEN1 mutation, alters mitochondrial networks and their degradation in Alzheimer's disease
    Costa-Laparra, Irene
    Juarez-Escoto, Elena
    Vicario, Carlos
    Moratalla, Rosario
    Garcia-Sanz, Patricia
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15